1-6 of 6
Francesco Dieli
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

IL4 Primes the Dynamics of Breast Cancer Progression via DUSP4 Inhibition

Miriam Gaggianesi, Alice Turdo, Aurora Chinnici, Elisa Lipari, Tiziana Apuzzo, Antonina Benfante, Isabella Sperduti, Simone Di Franco, Serena Meraviglia, Elena Lo Presti, Francesco Dieli, Valentina Caputo, Gabriella Militello, Salvatore Vieni, Giorgio Stassi, Matilde Todaro
Journal: Cancer Research
Cancer Res (2017) 77 (12): 3268–3279.
https://doi.org/10.1158/0008-5472.CAN-16-3126
Published: 14 June 2017
View article titled, IL4 Primes the Dynamics of Breast Cancer Progression via DUSP4 Inhibition
Open the PDF for IL4 Primes the Dynamics of Breast Cancer Progression via DUSP4 Inhibition in another window
Includes: Supplementary data
Journal Articles

Abstract LB-143: DNp63 governs metastatic outgrowth of breast cancer stem cells

Alice Turdo, Simone Di Franco, Antonina Benfante, Maria Luisa Colorito, Marco Bonanno, Miriam Gaggianesi, Daniela Barcaroli, Francesco Dieli, Jan Paul Medema, Vincenzo De Laurenzi, Giorgio Stassi, Matilde Todaro
Journal: Cancer Research
Cancer Res (2015) 75 (15_Supplement): LB-143.
https://doi.org/10.1158/1538-7445.AM2015-LB-143
Published: 01 August 2015
View article titled, Abstract LB-143: DNp63 governs metastatic outgrowth of breast cancer stem cells
Journal Articles

Tumorigenic and Metastatic Activity of Human Thyroid Cancer Stem Cells

Matilde Todaro, Flora Iovino, Vincenzo Eterno, Patrizia Cammareri, Guido Gambara, Virginia Espina, Gaspare Gulotta, Francesco Dieli, Silvia Giordano, Ruggero De Maria, Giorgio Stassi
Journal: Cancer Research
Cancer Res (2010) 70 (21): 8874–8885.
https://doi.org/10.1158/0008-5472.CAN-10-1994
Published: 31 October 2010
View article titled, Tumorigenic and Metastatic Activity of Human Thyroid Cancer Stem Cells
Open the PDF for Tumorigenic and Metastatic Activity of Human Thyroid Cancer Stem Cells in another window
Includes: Supplementary data
Journal Articles

Aurora-A Is Essential for the Tumorigenic Capacity and Chemoresistance of Colorectal Cancer Stem Cells

Patrizia Cammareri, Alessandro Scopelliti, Matilde Todaro, Vincenzo Eterno, Federica Francescangeli, Mary Pat Moyer, Antonino Agrusa, Francesco Dieli, Ann Zeuner, Giorgio Stassi
Journal: Cancer Research
Cancer Res (2010) 70 (11): 4655–4665.
https://doi.org/10.1158/0008-5472.CAN-09-3953
Published: 01 June 2010
View article titled, Aurora-A Is Essential for the Tumorigenic Capacity and Chemoresistance of Colorectal Cancer Stem Cells
Open the PDF for Aurora-A Is Essential for the Tumorigenic Capacity and Chemoresistance of Colorectal Cancer Stem Cells in another window
Includes: Supplementary data
Journal Articles

Suppressor of Cytokine Signaling 3 Sensitizes Anaplastic Thyroid Cancer to Standard Chemotherapy

Maria Giovanna Francipane, Vincenzo Eterno, Valentina Spina, Miriam Bini, Gregorio Scerrino, Giuseppe Buscemi, Gaspare Gulotta, Matilde Todaro, Francesco Dieli, Ruggero De Maria, Giorgio Stassi
Journal: Cancer Research
Cancer Res (2009) 69 (15): 6141–6148.
https://doi.org/10.1158/0008-5472.CAN-09-0994
Published: 29 July 2009
View article titled, Suppressor of Cytokine Signaling 3 Sensitizes Anaplastic Thyroid Cancer to Standard Chemotherapy
Open the PDF for Suppressor of Cytokine Signaling 3 Sensitizes Anaplastic Thyroid Cancer to Standard Chemotherapy in another window
Journal Articles

Targeting Human γδ T Cells with Zoledronate and Interleukin-2 for Immunotherapy of Hormone-Refractory Prostate Cancer

Francesco Dieli, David Vermijlen, Fabio Fulfaro, Nadia Caccamo, Serena Meraviglia, Giuseppe Cicero, Andrew Roberts, Simona Buccheri, Matilde D'Asaro, Nicola Gebbia, Alfredo Salerno, Matthias Eberl, Adrian C. Hayday
Journal: Cancer Research
Cancer Res (2007) 67 (15): 7450–7457.
https://doi.org/10.1158/0008-5472.CAN-07-0199
Published: 01 August 2007
View article titled, Targeting Human γδ T Cells with Zoledronate and Interleukin-2 for Immunotherapy of Hormone-Refractory Prostate Cancer
Open the PDF for Targeting Human γδ T Cells with Zoledronate and Interleukin-2 for Immunotherapy of Hormone-Refractory Prostate Cancer in another window
Includes: Supplementary data